| Product Focus :: EVK-001
EVK-001 is a novel gastrointestinal product in late stage development for the treatment of patients with diabetic gastroparesis. After the acquisition of EVK-001, Evoke has continued development work on the product and initiated additional clinical trials. Product registration will occur following a Phase 3 clinical trial which is expected to initiate in 2010. Evoke holds rights to intellectual property associated with EVK-001 granted by the United States Patent & Trademark Office with expiration dates through 2021.
Evoke is currently enrolling patients in a Phase 2b clinical trial to evaluate EVK-001 for the treatment of adults with symptoms of diabetic gastroparesis. Any persons interested in enrolling should contact clinical trial sites directly as listed here. Additional information about the trial can be found at www.clinicaltrials.gov.
| 
